Skip to main content
. 2007 Nov 13;93(2):400–409. doi: 10.1210/jc.2007-1134

Table 1.

Demographics and clinical details of patients recruited into trial

DHEA Placebo
n 54 52
Males 24 20
Females 30 32
Median age (range), yr 46 (23–65) 46 (22–65)
Median disease duration (range), yr 11 (1–46) 10 (1–49)
Hydrocortisone dose, mg per 24 h 25 27
Autoimmune thyroid disease 20 14
Type 1 diabetes mellitus 4 1
Pernicious anaemia 3 1
Vitiligo 3 1
Premature ovarian failure (HRT) 9 (8) 3 (2)
Post menopausal (HRT) 9 (4) 11 (6)

HRT, Hormone replacement therapy.